Research
Hormonal
Semaglutide 2.4 mg improves cardiometabolic risk factors, including blood pressure, lipids, glycated hemoglobin, and C-reactive protein, extending benefits beyond weight loss alone.
Beyond weight loss, semaglutide 2.4 mg helps improve blood pressure, cholesterol, blood sugar control, and inflammation markers. This makes it particularly beneficial for patients with obesity who also have related health risks like hypertension or diabetes.
StrongSupportsHIGH confidence
Improvements in blood pressure, lipids, glycated hemoglobin, and C-reactive protein, a marker of inflammation, were observed across the STEP 1–5 trials, demonstrating that the beneficial effects of once-weekly semaglutide 2.4 mg extend beyond weight loss alone.
Why this rating
Based on phase 3 STEP 1-5 trials.
Source
Integrating semaglutide into obesity management – a primary care perspective
Janine V. Kyrillos et al. · Postgraduate Medicine · 2022
narrative_reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →